A study of T320 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called T320, which is designed to target and kill cancer cells. It is for people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that cannot be removed with surgery and has not responded to standard treatments.
- You are 18 years or older.
- You have a tumor that can be measured on a scan (like a CT or MRI).
- Your overall health is good, with a performance status of 0 to 2 (meaning you can care for yourself and are out of bed more than half the day).
- You have adequate organ function, including blood counts, liver, kidney, and heart function.
- You have a tumor sample available from a previous biopsy or are willing to have a new one taken.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug called ATB-320 for people with solid tumors that have spread or are growing despite standard treatment. It aims to see if the drug is safe and tolerable.
This trial tests an experimental drug, BNT3214, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if BNT3214 is safe and helps shrink tumors.
This Phase 1 study tests how safe T-1201 (an injection) is in people with advanced solid tumors that are not responding to standard treatment. It mainly looks at side effects and tolerability, and it may offer a treatment option if other options are no longer working.
This early-phase study tests whether T-1301 capsules are safe and how well they can work in people with advanced solid tumors that can’t be treated with standard options. It focuses on side effects first, but results may help guide future treatment for advanced cancers.
This Phase 1 trial tests NBL-020, an injected medicine, in adults with advanced solid cancers (and possibly some skin T-cell lymphoma) to see how it works and how safe it is. You may be considered if standard treatment has stopped working or isn’t tolerated and if you can provide recent tumor tissue for lab testing.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
Hear when a new Advanced Solid Tumor (Phase 1) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.